Neurotransmitter Transporter Uptake Assay Kit, Molecular Devices
Supplier: INFINEUM Netherlands B.V.Total Ratings: 0
Avg. Ratings: 0.0 out of 5
Neurotransmitter transporters play a key role in depression and neurodegenerative diseases (NDD) such as Alzheimer's and Parkinson's.
- Replaces radioactive assays
- One-step, homogeneous assay format
- Two assay setup
The ability to monitor serotonin, norepinephrine and dopamine neurotransmitter uptake is key to a better understanding of these diseases.
Homogeneous, live-cell fluorescent assay replaces radioactive assays, reducing disposal costs and eliminating safety risks associated with radiolabeled assays. One-step, homogeneous assay format is amenable to automation and high-throughput screening. Two assay setup options offer greater flexibility: endpoint mode for high-throughput applications, or real-time kinetic mode for mechanistic studies.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...